Key result
Sotalol prevents inducible ventricular tachycardia and ventricular fibrillation in approximately 30% of patients and is superior to class I agents for life-threatening ventricular arrhythmias.
Why the study?
Does sotalol effectively control supraventricular and ventricular tachyarrhythmias?
Does sotalol effectively control supraventricular and ventricular tachyarrhythmias?
Sotalol is a major antifibrillatory compound effective for controlling life-threatening ventricular arrhythmias and maintaining sinus rhythm in atrial fibrillation and flutter.
No takes yet. Share an insight, caveat, or question.
Supports consideration for refractory ventricular arrhythmias; leaves open need for contemporary randomized comparisons.
Bramah N. Singh (1999) conducted a review in Supraventricular and ventricular tachyarrhythmias. Sotalol vs. Class I agents was evaluated on Prevention of inducible ventricular tachycardia (VT) and ventricular fibrillation (VF). Sotalol prevents inducible ventricular tachycardia and ventricular fibrillation in approximately 30% of patients and is superior to class I agents for life-threatening ventricular arrhythmias.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: